Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:FOSL News 16 October 2025

Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Stock’s Rollercoaster 2025 Performance Fossil Group’s stock has been on a wild ride in 2025, with dramatic swings that grabbed Wall Street’s attention. After years of decline, FOSL shares staged a comeback this year – up over 60% year-to-date, vastly outperforming the broader apparel/accessories sector Nasdaq. The rally hit a fever pitch in mid-October: on October 15, Fossil’s stock skyrocketed 41.5% in a single day, hitting $3.89 intraday (a multi-year high) and closing at $3.75 Stockinvest. This surge was seemingly out of nowhere, and traders scrambled to pinpoint the cause. As it turned out, a confluence of positive news
16 October 2025
·

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop